MOLLY HEBERLING: Open Payments
NPI 1063839520 · JACKSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 37 payments from 13 companies in 2025. Trend: 2023 $469 · 2024 $632 · 2025 $1,080
Food & beverage: $797Education: $283
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $359 |
| GENZYME CORPORATION | 6 | $144 |
| UCB, Inc. | 4 | $123 |
| ABBVIE INC. | 6 | $112 |
| E.R. Squibb & Sons, L.L.C. | 2 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| LEO Pharma Inc. | 1 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Botanix SB Inc | 1 | $23 |
| PFIZER INC. | 1 | $22 |
Products named: TREMFYA, DUPIXENT, Bimzelx, Sotyktu, SKYRIZI, RINVOQ, ADBRY, COSENTYX.
Industry payments across MI — which companies pay providers there.
